Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Assets Average (2016 - 2025)

International Stem Cell (ISCO) has disclosed Assets Average for 15 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average rose 0.51% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 million, a 0.51% increase, with the full-year FY2024 number at $5.3 million, changed 0.36% from a year prior.
  • Assets Average was $5.4 million for Q3 2025 at International Stem Cell, down from $5.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $5.8 million in Q2 2021 to a low of $4.9 million in Q4 2021.
  • A 5-year average of $5.4 million and a median of $5.4 million in 2025 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: dropped 16.51% in 2021, then rose 9.27% in 2023.
  • International Stem Cell's Assets Average stood at $4.9 million in 2021, then grew by 2.97% to $5.1 million in 2022, then grew by 8.39% to $5.5 million in 2023, then dropped by 6.15% to $5.2 million in 2024, then rose by 4.6% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Assets Average are $5.4 million (Q3 2025), $5.6 million (Q2 2025), and $5.4 million (Q1 2025).